The presentation included data generated by Theranos on several blood tests, but did not include any peer-reviewed data. After a host of operational lapses, the company voided then corrected two years of patients’ results from its proprietary Edison technology. Holmes replied that the presentation focused on the architecture of the company’s new technology and was an introduction to the invention. Theranos has experienced a rapid fall from grace, with federal regulators banning Holmes from owning or operating a lab for two years. This year, Theranos added a group of well-respected laboratory medicine experts to its medical and scientific advisory board.

Source: Washington Post August 02, 2016 00:56 UTC